Fate Therapeutics is a startup based in the United States, most recent round Series-c-plus.
Fate Therapeutics is a startup based in the United States. Its most recent tracked round is Series-c-plus.
Fate Therapeutics is a clinical-stage biopharmaceutical company developing induced pluripotent stem cell (iPSC)-derived, off-the-shelf cellular immunotherapies — including engineered NK and T cell products — for cancer and immune disorders.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.